BioSpace News Archive

Pfizer Inc. (NYSE: PFE) announced today that the European Commission (EC) has approved VYNDAQEL® (tafamidis), a once-daily 61 mg oral capsule, for the treatment of wild-type or hereditary transthyretin amyloidosis in adult patients with cardiomyopathy (ATTR-CM).

Akcea Therapeutics, Inc. (NASDAQ:AKCA), a majority-owned affiliate of Ionis Pharmaceuticals, Inc., announced today that it will host a live webcast on Tuesday, February 25 at 4:30 p.m. Eastern Time to discuss its 2019 financial results and report on pipeline and business progress.

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced that the company is scheduled to present at the Cowen 40th Annual Healthcare Conference in Boston on Tuesday, March 3, 2020 at 11:20 a.m. ET.

MMI SpA, an Italian company dedicated to improving clinical outcomes for patients undergoing microsurgery, announced the appointment of Ryan Rhodes to the position of Global Chief Commercial Officer.

Industry veterans Joel Morse and Dave Hanaman announce the formation of a company to lead into the future of clinical trials

SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, today announced that Saqib Islam, Chief Executive Officer, will present at the Cowen and Company 40th Annual Health Care Conference in Boston on Tuesday, March 3, 2020

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, and Vision Center Network of America, LLC (“VCNA”), a Clinically Integrated Network (“CIN”) with the aim of significantly improving the healthcare delivery system in the specialty area of ophthalmic surgery, today announced that they have entered into an purchase agreement for DEXYCU